EGM
TVTX icon

Engineers Gate Manager’s Travere Therapeutics TVTX Stock Holding History

Engineers Gate Manager’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
47,003
-207,398
-82% -$9.2M 0.03% 572
2026
Q1 		$7.56M Buy
254,401
+117,793
+86% +$3.52M 0.09% 252
2025
Q4 		$5.22M Buy
136,608
+96,918
+244% +$3.15M 0.06% 329
2025
Q3 		$949K Sell
39,690
-71,117
-64% -$1.34M 0.01% 1181
2025
Q2 		$1.64M Buy
110,807
+21,023
+23% +$348K 0.02% 844
2025
Q1 		$1.61M Buy
+89,784
New +$1.82M 0.03% 801
2024
Q4 		– Sell
-62,245
Closed -$871K – 2585
2024
Q3 		$871K Buy
62,245
+20,485
+49% +$213K 0.02% 1087
2024
Q2 		$343K Buy
+41,760
New +$281K 0.01% 1392
2023
Q4 		– Sell
-108,375
Closed -$969K – 2274
2023
Q3 		$969K Buy
108,375
+48,485
+81% +$684K 0.04% 724
2023
Q2 		$920K Buy
59,890
+36,618
+157% +$666K 0.03% 738
2023
Q1 		$523K Buy
+23,272
New +$495K 0.02% 955
2022
Q4 		– Sell
-17,762
Closed -$438K – 2047
2022
Q3 		$438K Buy
+17,762
New +$459K 0.03% 898
2022
Q2 		– Sell
-16,331
Closed -$421K – 2272
2022
Q1 		$421K Sell
16,331
-7,469
-31% -$198K 0.02% 1163
2021
Q4 		$739K Buy
23,800
+7,646
+47% +$215K 0.03% 784
2021
Q3 		$392K Buy
+16,154
New +$297K 0.02% 1034
2020
Q4 		– Sell
-13,420
Closed -$248K – 1994
2020
Q3 		$248K Buy
+13,420
New +$261K 0.01% 1341
2020
Q2 		– Sell
-10,860
Closed -$158K – 1980
2020
Q1 		$158K Sell
10,860
-1,591
-13% -$23.9K 0.01% 1324
2019
Q4 		$177K Buy
+12,451
New +$159K 0.01% 1493

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's TVTX Position: Q2 2026 in Review

Engineers Gate Manager reduced its Travere Therapeutics (TVTX) stake by 82% in Q2 2026, selling an estimated $9.2M and leaving 47,003 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #572.

Engineers Gate Manager first reported a position in TVTX in Q4 2019 and has held it in 18 quarters since. The position peaked at $7.56M in Q1 2026. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Engineers Gate Manager held 47,003 shares of Travere Therapeutics worth $2.67M as of Q2 2026.
  • Engineers Gate Manager sold 207,398 Travere Therapeutics shares in Q2 2026, an estimated $9.2M.
  • Travere Therapeutics made up 0.03% of Engineers Gate Manager's portfolio in Q2 2026, its #572 holding.
  • Engineers Gate Manager first reported a position in Travere Therapeutics in Q4 2019 and has held it in 18 quarters since.
  • Engineers Gate Manager's Travere Therapeutics position peaked at $7.56M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.